Log in

Development of a useful single-reference HPLC method for therapeutic drug monitoring of phenytoin and carbamazepine in human plasma

  • Special Issue: Original Paper
  • Frontiers of Separation Analysis
  • Published:
Analytical Sciences Aims and scope Submit manuscript

Abstract

A single reference high-performance liquid chromatographic (SR-HPLC) method was developed and validated for the therapeutic drug monitoring (TDM) of phenytoin (PHT) and carbamazepine (CBZ) in plasma from patients. The analytical parameters evaluated were linearity, limit of quantification (LOQ), selectivity, accuracy, and stability according to the US Food and Drug Administration (FDA) guideline. The developed method shows good linearity (r2 > 0.999; LOQ—50 µg/mL), and LOQ values were 1.56 µg/mL for PHT and 0.40 µg/mL for CBZ at 254 nm. For the development of SR-HPLC method, we evaluated to improve the detection wavelength, stirred retention time, and stability for SR, and selected 5-(p-methylphenyl)-5-phenylhydantoin for PHT (relative molar sensitivity, RMS = 0.848) and 10-methoxyiminostilbene for CBZ (RMS = 0.263). The established differential definite quantities of PHT and CBZ in plasma samples were similar using the RMS and absolute calibration methods based on RSD < 5.10%. A preliminary application was performed using chemiluminescent immunoassay and SR-HPLC method, in which the detectable values of the correlation coefficient and the slope of the intercept were PHT: 0.964 and 0.992647, and CBZ: 0.969 and 1.072089, respectively. Based on these results, we propose that the SR-HPLC method with RMS would be offered to the useful and accurate TDM of various medicines in plasma/serum samples.

Graphical abstract

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price includes VAT (France)

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

Data availability

On reasonable request, derived data supporting the findings of this study are available from the corresponding author after approval from the Ethical Committee of the Ritsumeikan University.

References

  1. S.H.Y. Wong, J. Pharm. Biomed. Anal. (1989). https://doi.org/10.1016/0731-7085(89)80041-X

    Article  PubMed  Google Scholar 

  2. A.H. Kumps, J. Pharm. Biomed. Anal. (1982). https://doi.org/10.1007/BF00313405

    Article  Google Scholar 

  3. H.M. Neels, A.C. Sierens, K. Naelaerts, S.L. Scharpé, G.M. Hatfield, W.E. Lambert, Clin. Chem. Lab. Med. (2004). https://doi.org/10.1515/CCLM.2004.245

    Article  PubMed  Google Scholar 

  4. P.A. Datar, J. Pharm. Anal. (2015). https://doi.org/10.1016/j.jpha.2015.02.005

    Article  PubMed  PubMed Central  Google Scholar 

  5. D.C. Turnell, S.C. Trevor, J.D. Cooper, Ann. Clin. Biochem. (1983). https://doi.org/10.1177/000456328302000106

    Article  PubMed  Google Scholar 

  6. H. Sayo, H. Hatsumura, M. Hosokawa, J. Chromatogr. (1988). https://doi.org/10.1016/s0378-4347(00)81978-7

    Article  PubMed  Google Scholar 

  7. G.K. Szabo, R.J. Pylilo, R.J. Perchalski, T.R. Browne, J. Chromatogr. (1990). https://doi.org/10.1016/s0021-9673(01)88952-4

    Article  PubMed  Google Scholar 

  8. B. Rambeck, T.W. May, M.U. Jürgens, V. Blankenhorn, U. Jürges, E. Korn-Merker, A. Sälke-Kellermann, Ther. Drug Monit. (1994). https://doi.org/10.1097/00007691-199412000-00013

    Article  PubMed  Google Scholar 

  9. K.M. Patil, S.L. Bodhankar, J. Pharm. Biomed. Anal. (2005). https://doi.org/10.1016/j.jpba.2005.02.045

    Article  PubMed  Google Scholar 

  10. E. Greiner-Sosanko, D.R. Lower, M.A. Virji, M.D. Krasowski, Biomed. Chromatogr. (2007). https://doi.org/10.1002/bmc.753

    Article  PubMed  PubMed Central  Google Scholar 

  11. M.J. Tutor-Crespo, J. Hermida, J.C. Tutor, J. Clin. Lab. Anal. (2007). https://doi.org/10.1002/jcla.20115

    Article  PubMed  PubMed Central  Google Scholar 

  12. J. Hermida, M.D. Bóveda, F.J. Vadillo, J.C. Tutor, Clin. Biochem. (2002). https://doi.org/10.1016/s0009-9120(02)00299-0

    Article  PubMed  Google Scholar 

  13. Ó. Guerrero Garduño, D.F. González-Esquivel, C. Escalante-Membrillo, Á. Fernández, I.S. Rojas-Tomé, H. Jung Cook, N. Castro, Biomed. Chromatogr. (2016) https://doi.org/10.1002/bmc.3631

  14. T. Liu, R.R. Kotha, J.W. Jones, J.E. Polli, M.A. Kane, J. Pharm. Biomed. Anal. (2019). https://doi.org/10.1016/j.jpba.2019.112816

    Article  PubMed  PubMed Central  Google Scholar 

  15. S.T. Hassib, H.M.A. Hashem, M.A. Mahrouse, E.A. Mostafa, Biomed. Chromatogr. (2018). https://doi.org/10.1002/bmc.4253

    Article  PubMed  Google Scholar 

  16. L. Yin, T. Wang, M. Shi, Y. Zhang, X. Zhao, Y. Yang, J. Gu, J. Sep. Sci. (2016). https://doi.org/10.1002/jssc.201501067

    Article  PubMed  Google Scholar 

  17. M. Takahashi, Y. Nishizaki, N. Sugimoto, K. Sato, K. Inoue, J. Chromatogr. A (2018). https://doi.org/10.1016/j.chroma.2018.04.029

    Article  PubMed  Google Scholar 

  18. M. Takahashi, Y. Nishizaki, K. Morimoto, N. Sugimoto, K. Sato, K. Inoue, Sep. Sci. Plus 1(2018) https://doi.org/10.1002/sscp.201800081

  19. M. Takahashi, Y. Nishizaki, N. Masumoto, N. Sugimoto, K. Sato, K. Inoue, J. Sci. Food Agric. (2021). https://doi.org/10.1002/jsfa.11013

    Article  PubMed  Google Scholar 

  20. M. Takahashi, K. Morimoto, Y. Nishizaki, N. Masumoto, N. Sugimoto, K. Sato, K. Inoue, Chem. Pharm. Bull. (2022). https://doi.org/10.1248/cpb.c21-00621

    Article  Google Scholar 

  21. Guidance for Industry, Bionanalytical Method Validation, US Department of Health and Human Services/Food and Drug Administration Centre for Drug Evaluation and Research (CDER)/Centre for Veterinary Medicine (CVM), 2018, May.

  22. H. Passing, Bablok. J. Clin. Chem. Clin. Biochem. (1983). https://doi.org/10.1515/cclm.1983.21.11.709

    Article  PubMed  Google Scholar 

  23. R.H. Queiroz, C. Bertucci, W.R. Malfará, S.A. Dreossi, A.R. Chaves, D.A. Valério, M.E. Queiroz, J. Pharm. Biomed. Anal. (2008). https://doi.org/10.1016/j.jpba.2008.03.020

    Article  PubMed  Google Scholar 

  24. M.M. Bhatti, G.D. Hanson, L. Schultz, J. Pharm. Biomed. Anal. (1998). https://doi.org/10.1016/s0731-7085(97)00265-3

    Article  PubMed  Google Scholar 

  25. The Japanese Pharmacopoeia, Eighteenth Edition, 2.46 Residual Solvents, June 7 (2021) 58–64. https://www.mhlw.go.jp/content/11120000/000943877.pdf

  26. A. Dasgupta, M.A. Reyes, B.G. Davis, A.M. Marlow, M. Johnson, J. Clin. Lab. Anal. (2010). https://doi.org/10.1002/jcla.20400

    Article  PubMed  PubMed Central  Google Scholar 

  27. G.A. McMillin, J.M. Juenke, G. Tso, A. Dasgupta, Am. J. Clin. Pathol. (2010). https://doi.org/10.1309/AJCPFAHVB26VVVTE

    Article  PubMed  Google Scholar 

  28. G.A. McMillin, J.M. Juenke, M.J. Johnson, A. Dasgupta, J. Clin. Lab. Anal. (2011). https://doi.org/10.1002/jcla.20460

    Article  PubMed  PubMed Central  Google Scholar 

  29. R. Takahashi, K. Imai, S. Sugai, T. Yoshida, M. Nakamura, S. Hamano, F. Iwasaki, Iryo Yakugaku. (2012). https://doi.org/10.5649/jjphcs.38.741

    Article  Google Scholar 

  30. D.A. Svinarov, C.E. Pippenger, Ther. Drug Monit. (1996). https://doi.org/10.1097/00007691-199612000-00006

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

We thank Dr. Miki Takahashi, Dr. Yuzo Nishizaki, Dr. Naoki Sugimoto, and Dr. Kyoko Sato from National Institute of Health Sciences, Japan for their technical assistance and SR advice.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yuko Sakaguchi.

Ethics declarations

Conflict of interest

The authors declare that they have no known competing financial interests or personal relationships that could have influenced the work reported in this study.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 80 KB)

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sakaguchi, Y., Arima, R., Maeda, R. et al. Development of a useful single-reference HPLC method for therapeutic drug monitoring of phenytoin and carbamazepine in human plasma. ANAL. SCI. 39, 447–454 (2023). https://doi.org/10.1007/s44211-023-00266-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s44211-023-00266-z

Keywords

Navigation